Top Midday Decliners

MT Newswires Live03-04

Power Solutions International (PSIX) reported late Monday that Q4 non-GAAP net income declined from a year earlier.

Shares sank 25% following an increase in intraday trading volume to over 1.5 million from a daily average of about 450,000.

Theravance Biopharma (TBPH) shares sank 28% after the company said Tuesday its blood pressure drug ampreloxetine failed to meet its primary endpoint in a phase 3 trial.

Intraday trading volume jumped to over 3 million shares from a daily average of about 459,000.

Harrow (HROW) reported a decline in Q4 earnings that also missed analysts' expectations late Monday.

Shares sank 25% as intraday trading volume jumped to over 2.7 million from a daily average of about 565,000.

Price: 39.96, Change: -13.63, Percent Change: -25.43

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2616752393?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-04 03:17","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2616752393","market":"us","top_or_hot":-1,"title":"Top Midday Decliners","media":"MT Newswires Live","content":"<html><body><p> Power Solutions International (PSIX) reported late Monday that Q4 non-GAAP net income declined from a year earlier.</p><p>Shares sank 25% following an increase in intraday trading volume to over 1.5 million from a daily average of about 450,000.</p><p><a href=\"https://laohu8.com/S/TBPH\">Theravance Biopharma</a> (TBPH) shares sank 28% after the company said Tuesday its blood pressure drug ampreloxetine failed to meet its primary endpoint in a phase 3 trial.</p><p>Intraday trading volume jumped to over 3 million shares from a daily average of about 459,000.</p><p>Harrow (HROW) reported a decline in Q4 earnings that also missed analysts' expectations late Monday.</p><p>Shares sank 25% as intraday trading volume jumped to over 2.7 million from a daily average of about 565,000.</p><p>Price: 39.96, Change: -13.63, Percent Change: -25.43</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Midday Decliners</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Midday Decliners\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-03-04 03:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Power Solutions International (PSIX) reported late Monday that Q4 non-GAAP net income declined from a year earlier.</p><p>Shares sank 25% following an increase in intraday trading volume to over 1.5 million from a daily average of about 450,000.</p><p><a href=\"https://laohu8.com/S/TBPH\">Theravance Biopharma</a> (TBPH) shares sank 28% after the company said Tuesday its blood pressure drug ampreloxetine failed to meet its primary endpoint in a phase 3 trial.</p><p>Intraday trading volume jumped to over 3 million shares from a daily average of about 459,000.</p><p>Harrow (HROW) reported a decline in Q4 earnings that also missed analysts' expectations late Monday.</p><p>Shares sank 25% as intraday trading volume jumped to over 2.7 million from a daily average of about 565,000.</p><p>Price: 39.96, Change: -13.63, Percent Change: -25.43</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HROW","symbol_name":"Harrow Health Inc","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2616752393","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2616752393","pubTimestamp":1772565444,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Power Solutions International  reported late Monday that Q4 non-GAAP net income declined from a year earlier.Shares sank 25% following an increase in intraday trading volume to over 1.5 million from a daily average of about 450,000.Theravance Biopharma  shares sank 28% after the company said Tuesday its blood pressure drug ampreloxetine failed to meet its primary endpoint in a phase 3 trial.Intraday trading volume jumped to over 3 million shares from a daily average of about 459,000.Harrow  reported a decline in Q4 earnings that also missed analysts' expectations late Monday.Shares sank 25% as intraday trading volume jumped to over 2.7 million from a daily average of about 565,000.Price: 39.96, Change: -13.63, Percent Change: -25.43","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HROW":"Harrow Health Inc","BK4182":"重型电气设备","BK4557":"大麻股","BK4007":"制药","TBPH":"Theravance Biopharma Inc.","PSIX":"Power Solutions Intl Inc"},"translate_title":"午盘跌幅最大的股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TBPH":1,"HROW":1,"PSIX":1},"content_text":"Power Solutions International (PSIX) reported late Monday that Q4 non-GAAP net income declined from a year earlier.Shares sank 25% following an increase in intraday trading volume to over 1.5 million from a daily average of about 450,000.Theravance Biopharma (TBPH) shares sank 28% after the company said Tuesday its blood pressure drug ampreloxetine failed to meet its primary endpoint in a phase 3 trial.Intraday trading volume jumped to over 3 million shares from a daily average of about 459,000.Harrow (HROW) reported a decline in Q4 earnings that also missed analysts' expectations late Monday.Shares sank 25% as intraday trading volume jumped to over 2.7 million from a daily average of about 565,000.Price: 39.96, Change: -13.63, Percent Change: -25.43","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2616752393","isCrawlerRequest":true}